AKT1 and cardiac hypertrophy: Further studies showed that S1P/S1pr1 praxis activated AKT/eNOS signalling pathways and enhanced the production of NO, which contributed to the protective effect of EC‐S1pr1 on cardiac hypertrophy and fibrosis.